SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-20-027161
Filing Date
2020-12-02
Accepted
2020-12-02 21:10:01
Documents
2
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 4929
2 EXHIBIT 24 brhc10017509_ex24.htm EX-24 6207
  Complete submission text file 0001140361-20-027161.txt   12510
Mailing Address C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560
Business Address
Kaldor Stephen W (Reporting) CIK: 0001507502 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39743 | Film No.: 201365503

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations